Original Research Article
DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20203962
Serum vitamin D3 deficiency among cases with extensive tinea corporis infection
Department of Dermatology, Venereology and Leprosy, Sri Muthukumaran Medical College Hospital & Research Institute, Chennai, Tamil Nadu, India
Received: 04 August 2020
Accepted: 26 August 2020
*Correspondence:
Dr. Shahul Hameed G,
E-mail: drshahulg86@gmail.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Background: Abnormal serum vitamin D3 levels have been implicated as risk factors for development of various skin disorders. Hence this study was planned to assess the prevalence of vitamin D3 deficiency among patients with Tinea corporis who were attending outpatient department of dermatology in a tertiary care centre.
Methods: The cross sectional study was conducted by the department of dermatology, venereology and leprosy, at Sri Muthukumaran Medical College Hospital and Research Institute, among the patients attending the outpatient department, during the month of June to August 2019. A total of fifty cases with extensive Tinea corporis infection were included in the study. The study was conducted using a proforma with the detailed clinical history and also patients underwent skin scrapping for KOH mount and serum vitamin D3 analysis. Data was entered in Microsoft excel and data analysis was done using Statistical Package for Social Sciences (SPSS) version 17.
Results: Among the cases with extensive Tinea corporis infection, only 20% of cases were found to have normal levels of serum vitamin D3 whereas 48.3% of cases were found to have serum vitamin D3 insufficiency and 31.7% of cases had deficiency of serum vitamin D3
Conclusions: Screening for vitamin D3 deficiency for all cases with extensive Tinea corporis infection can be recommended. Further large scale clinical trials are needed to assess whether vitamin D3 deficiency has any role to play in pathogenesis and treatment of extensive Tinea corporis infection.
Keywords: Vitamin D, Tinea corporis, Prevalence, Deficiency
INTRODUCTION
Vitamin D plays an important role in cutaneous physiology and mediating the immune system response. It helps in envelope formation and synthesis of the lipid permeability barrier.1 Apart from this function it also stimulates the production of human cathelicidin, an antimicrobial peptide, which prevents skin disorders like atopic dermatitis.2,3
The American academy of pediatrics recommends a daily intake of 400 IU of vitamin D3 for infants and children, while the Institute of Medicine and The Endocrine Society recommend 400 IU daily for infants and 600 IU daily and 200 IU/day for children (1-18 years) and adults, respectively.4,5
The normal range of serum vitamin D3 is 50-125 nmol/l and vitamin D deficiency refers to serum vitamin D levels between 30-50 nmol/l and vitamin D3 deficiency refers to serum vitamin D3 levels <30 nmol/l. Also high levels of serum vitamin D3 refer to values more than 125 nmol/l.5
Several studies reported an positive association between serum vitamin D3 levels and season, race, and age.6,7
Since ultraviolet light exposure is necessary for vitamin D3 synthesis, it is not surprising that race and season have a significant impact on vitamin D3 status. The reason for the inverse relationship between serum vitamin D3 levels and age is unclear, though some authors have theorized that older children may have decreased oral supplementation or spend less time playing outdoors.8
The results of the studies conducted before shows conflicting information about the role of vitamin D in the cases with skin disorders. Both decreased and increased serum vitamin D3 levels have been implicated as risk factors for development of various skin disorders like atopic dermatitis, psoriasis and Tinea infections.9,10 Also there were studies proved that improvement of atopic dermatitis after oral supplementation with vitamin D3 has also been reported.11,12
Hence this study was planned to assess the prevalence of serum vitamin D3 deficiency among the cases with extensive tinea infection, attending a tertiary health care centre.
Objectives
To assess the prevalence of vitamin D3 deficiency among patients with extensive Tinea infection who were attending outpatient department of dermatology in a tertiary care centre.
METHODS
The cross-sectional study was conducted by the department of dermatology, venereology and leprosy, at Sri Muthukumaran Medical College Hospital and Research Institute, among the adult’s patients (18-60 years) attending the outpatient department, during the month of June to August 2019. All patients with extensive tinea infection who were attending the outpatient Department of dermatology, venereology and leprosy were included in the study. Participants who were immunocompromised were excluded from the study. A total of fifty cases with extensive tinea infection were included in the study.
The individual participants were explained about the study and they were also assured that, their identity would be kept strictly confidential and they have the option to refuse participation in the study. Written informed consent was obtained from the study participant prior to the interview. Every effort was made, to be sure that all information collected from the participants, remain confidential. The study was conducted using a proforma with the detailed clinical history and also patients underwent skin scrapping for KOH mount and serum vitamin D3 analysis. The scoring of pruritus was graded on four point severity scale where nil(0), 1(mild), 2(moderate) and 3(severe). Data was entered in Microsoft excel and data analysis was done using Statistical Package for Social Sciences (SPSS) version 17.
RESULTS
In the present study, majority of the participants (26.7%) were belonging to age group of 31-40 years followed by 25% and 21.7% of participants in 41-50 years and 21-30 years of age, respectively. Also there were 20% and 6.7% of participants in the age group more than 50 years and between 18-20 years of age, respectively. The mean age of the study participants was found to be 37.56±12.71 years. With respect to gender, there were 58.3% and 41.7% of participants were males and females, respectively (Table 1).
In this study among the study participants only 20% of cases with extensive tinea corporis infection were found to have normal levels of serum vitamin D3 whereas 48.3% of cases were found to have serum vitamin D3 insufficiency and 31.7% of cases had deficiency of serum vitamin D3 (Figure 1).
Proportion of cases with different scores of pruritus, erythema and scaling with respect to their vitamin D3 levels were shown in Table 2. KOH mount showed positive in 96.7% of cases and only 3.3% of cases it was reported as negative.
In this study, majority of the study participants (71.7%) had extensive tinea corporis followed by 21.7% of cases with extensive tinea corporis et cruris and 3.3% of cases with extensive tinea corporis et faceii and extensive tinea corporis et glutealis each Table 3.
DISCUSSION
In this present study, majority of the study participants (71.7%) had extensive tinea corporis followed by 21.7% of cases with extensive tinea corporis et cruris and 3.3% of cases with extensive Tinea corporis et faceii and extensive tinea corporis et glutealis, each.
In this study among the study participants only 20% of cases were found to have normal levels of serum vitamin D3 whereas 48.3% of cases were found to have serum vitamin D3 insufficiency and 31.7% of cases had deficiency of serum vitamin D3.
Female sex has been associated with lower serum vitamin D3 levels in the studies conducted by Andiran et al and Tolppannan et al.6,13 Also body mass index has been inversely correlated with serum vitamin D3 levels although this association did not reach statistical significance in the studies conducted by Andiran et al and Stoian et al.6,7
Miyake et al found higher levels of maternal vitamin D intake protective against the development of atopic dermatitis, while there was no effect of maternal vitamin D intake on atopic dermatitis risk in a study by Camargo et al.14,15 In contrast, a study in obese adults found that those who were vitamin D deficient were 5 times more likely to have atopic dermatitis than those who were vitamin D replete.9
In the study conducted by Chiu et al, it was reported that serum vitamin D deficiency was present in 39% of cases, insufficiency was noted among 35% and sufficiency was noted among only 26% of cases.16
Vitamin D regulates diverse aspects of the immune system. Vitamin D receptors are located on many im-mune cells, including monocytes, macrophages, T and B lymphocytes, and dendritic cells. Several experimental studies have shown that vitamin D can enhance innate immune clearance of pathogens and promote proliferation and secretion of highly inflammatory interleukin-1.17,18 Vitamin D deficiency has been associated with increased incidence of infectious disease, especially respiratory tract diseases, and infection-associated mortality in the general population.19,20
CONCLUSION
The prevalence of serum vitamin D3 deficiency and insufficiency is quite high among the cases with Tinea infection. Hence public access to vitamin D through diet and UV exposure requires more attention. Also screening for vitamin D deficiency among all cases with Tinea infection can be recommended for all cases with Tinea infection. Further large scale clinical trials are needed to assess whether vitamin D deficiency is a predisposing factor for causing Tinea infection.
ACKNOWLEDGEMENTS
We would like to thank all, who has guided me by extending their knowledge and experience right from the inception to the completion of the work. Also, I would like to acknowledge the medical superintendent and all the staffs, for their support during the study period. Last but not least I am thankful to my study participants, without whom, this study would not have been possible.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: The study was approved by the institutional ethics committee
REFERENCES
- 1. Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347:80-9.
- 2. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25- dihydroxy-vitamin D3 is a direct inducer of antimicrobial pep-tide gene expression. J Immunol. 2004;173:2909-12.
- 3. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous anti-microbial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151-60.
- 4. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011.
- 5. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington National Academy Press. Available at: https://www.ncbi.nlm.nih.gov/books/NBK45188/. Accessed on 25 July 2020.
- 6. Andiran N, Celik N, Akca H, Dogan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol. 2012;4:25-9.
- 7. Stoian CA, Lyon M, Cox RG, Stephure DK, Mah JK. Vitamin D concentrations among healthy children in Calgary, Alberta. Paediatr Child Health. 2011;16:82-6.
- 8. Weng FL, Shults J, Leonard MB, Stallings VA, Zemel BS. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr. 2007;86:150-8.
- 9. Oren E, Banerji A, Camargo CA Jr. Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J Allergy Clin Immunol. 2008;121:533-4.
- 10. Back O, Blomquist HK, Hernell O, Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol. 2009;89:28-32.
- 11. Javanbakht MH, Keshavarz SA, Djalali M, Siassi F, Eshraghian MR, Firooz A, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog Treat. 2011;22:144-50.
- 12. Amestejani M, Salehi BS, Vasigh M, Sobhkhiz A, Karami M, Alinia H, et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol. 2012;11:327-30.
- 13. Tolppanen AM, Fraser A, Fraser WD, Lawlor DA. Risk factors for variation in 25-hydroxyvitamin D(3) and D(2) concentrations and vitamin D deficiency in children. J Clin Endocrinol Metab. 2012;97:1202-10.
- 14. Miyake Y, Sasaki S, Tanaka K, Hirota Y. Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur Respir J. 2010;35:1228-34.
- 15. Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 years of age. Am J Clin Nutr. 2007;85:788-95.
- 16. Chiu YE, Havens PL, Siegel DH, Ali O, Wang T, Holland KE, et al. Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. Journal of the American Academy Dermatol. 2013;69(1):40-6.
- 17. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol. 1986;98:311-22.
- 18. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-12.
- 19. Gou X, Pan L, Tang F, Gao H, Xiao D. The association between vitamin D status and tuberculosis in children: A meta-analysis. Medicine (Baltimore). 2018;97(35):e12179.
- 20. De Haan K, Groeneveld AB, De Geus HR, Egal M, Struijs A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care. 2014;18:660.